You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
梅斯健康(02415.HK)上半年營收1.11億元 毛利率同比上升約3.1%
格隆匯 08-31 00:14

格隆匯8月31日丨梅斯健康(02415.HK)公佈中期業績,截至2024年6月30日止六個月,公司收益為人民幣1.11億元,同比減少26.9%;毛利為人民幣6793.6萬元,同比減少23.1%;母公司擁有人應占溢利為人民幣24.8萬元,同比減少97.9%。

報吿期內,毛利率同比上升約3.1%,主要是因為集團積極響應國家號召,配合藥企客户進行了嚴格的合規審查,以確保所有學術研究與推廣業務符合國家最新的合規標準。儘管這些審查使項目執行和結算週期略有延長暫時影響了項目執行和完工結算的週期,導致營收下降,但這是為了確保所有業務的長期合規性和可持續發展。隨着合規審查的逐步完成和新標準的實施,集團預期項目執行速度將逐步恢復正常,並有望在未來進一步加速。。

截至2024年6月30日,集團已擁有超過5.1百萬會員,其中約3.2百萬名註冊醫生會員,臨牀研究數據、臨牀研究成果、醫療產品資訊、醫療專業人士的知識洞見構成龐大的知識庫,應用於醫療行業的各個領域。同時,集團也吸引更多的醫院、專家、藥企、研究者們不斷加入其網路。

截至2024年6月30日,集團累計向12家中國頂級研究型醫院提供醫療解決方案,並已覆蓋超過2,000家醫院,覆蓋範圍從一線及二線城市,擴張到下沉的縣域和基層醫療機構。集團累計服務的藥械企業數量截至2024年6月30日達到591家。

截至2024年6月30日,集團的梅斯醫學平台涉及了42個研究領域,包含了686,500條醫學資訊,較截至2023年12月31日增加8,650多條;包含了133,550個用户社區,較截至2023年12月31日增加200多個用户社區;維持了8,089個醫生社羣,較截至2023年12月31日增加2,025多個醫生社羣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account